Health
Has The Market Overpriced Moderna’s Vaccine? – Forbes
Moderna stock has jumped by about 4x this year adding over $20 billion in market value, as investors bet that a successful Covid-19 vaccine could generate windfall profits for the clinical-stage biotech company. Is this jump in valuation warranted? We don’t t…
Medical syringe is seen with Moderna company logo displayed on a screen in the background in this ……
Continue Reading
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business12 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…